CellSource Co., Ltd. (JP:4880) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CellSource Co., Ltd. will commence consolidated financial reporting starting from the fiscal year ending October 31, 2025, following the establishment of its subsidiary, Hybrid Medical Co., Ltd. The company has released its financial forecasts, projecting net sales of 4,501 million yen and a profit of 255 million yen for the upcoming fiscal year. These forecasts include the anticipated performance of Hybrid Medical.
For further insights into JP:4880 stock, check out TipRanks’ Stock Analysis page.